Ocuphire Pharma
summary of positive phase results for eye drops | Ocuphire Pharma
Company
Deck Type
Deck date
June 2021
Slide
23 of 33
Related slides by other companies
Innoviva
Results
November 2023
top line summary positive phase results | Innoviva
Oculis
SPAC
October 2022
phase a positive results in | Oculis
Oculis
Results
August 2023
innovative diversified and late stage pipeline | Oculis
MindMed
Investor Presentation
June 2023
phase study results key phase study results support progression of results from phase progression of clinical trial demonstrate tolerability and support linear maintained across the tested doses and clinical effects align with potent regimen suitable regimen in withdrawal aligns with preclinical evidence offers potential to be a more frequencies engagement | MindMed
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io